|
1
|
Khoury JD, Solary E, Abla O, Akkari Y,
Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, et
al: The 5th edition of the World Health Organization Classification
of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic
neoplasms. Leukemia. 36:1703–1719. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Emile JF, Cohen-Aubart F, Collin M,
Fraitag S, Idbaih A, Abdel-Wahab O, Rollins BJ, Donadieu J and
Haroche J: Histiocytosis. Lancet. 398:157–170. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Goyal G, Heaney ML, Collin M, Cohen-Aubart
F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M,
Jacobsen ED, Toyama K, et al: Erdheim-Chester disease: Consensus
recommendations for evaluation, diagnosis, and treatment in the
molecular era. Blood. 135:1929–1945. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Haroche J, Cohen-Aubart F, Rollins BJ,
Donadieu J, Charlotte F, Idbaih A, Vaglio A, Abdel-Wahab O, Emile
JF and Amoura Z: Histiocytoses: Emerging neoplasia behind
inflammation. Lancet Oncol. 18:e113–e125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Campochiaro C, Tomelleri A, Cavalli G,
Berti A and Dagna L: Erdheim-Chester disease. Eur J Intern Med.
26:223–229. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
McClain KL, Bigenwald C, Collin M, Haroche
J, Marsh RA, Merad M, Picarsic J, Ribeiro KB and Allen CE:
Histiocytic disorders. Nat Rev Dis Primers. 7(73)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan
MH, Liang ZY and Zhou DB: Evaluation of clinicopathologic
characteristics and the BRAF V600E mutation in Erdheim-Chester
disease among Chinese adults. Ann Hematol. 95:745–750.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Diamond EL, Dagna L, Hyman DM, Cavalli G,
Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML,
Scheel PJ, et al: Consensus guidelines for the diagnosis and
clinical management of Erdheim-Chester disease. Blood. 124:483–492.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Papo M, Cohen-Aubart F, Trefond L, Bauvois
A, Amoura Z, Emile JF and Haroche J: Systemic Histiocytosis
(langerhans cell histiocytosis, erdheim-chester disease,
destombes-rosai-dorfman disease): From oncogenic mutations to
inflammatory disorders. Curr Oncol Rep. 21(62)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cohen Aubart F, Emile JF, Carrat F,
Charlotte F, Benameur N, Donadieu J, Maksud P, Idbaih A, Barete S,
Hoang-Xuan K, et al: Targeted therapies in 54 patients with
Erdheim-Chester disease, including follow-up after interruption
(the LOVE study). Blood. 130:1377–1380. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Campochiaro C, Cavalli G, Farina N,
Tomelleri A, De Luca G and Dagna L: Efficacy and improved
tolerability of combination therapy with interleukin-1 blockade and
MAPK pathway inhibitors for the treatment of Erdheim-Chester
disease. Ann Rheum Dis. 81(e11)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Arnaud L, Hervier B, Néel A, Hamidou MA,
Kahn JE, Wechsler B, Pérez-Pastor G, Blomberg B, Fuzibet JG,
Dubourguet F, et al: CNS involvement and treatment with
interferon-α are independent prognostic factors in Erdheim-Chester
disease: A multicenter survival analysis of 53 patients. Blood.
117:2778–2782. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Miller RC, Villà S, Kamer S, Pasquier D,
Poortmans P, Micke O and Call TG: Palliative treatment of
Erdheim-Chester disease with radiotherapy: A rare cancer network
study. Radiother Oncol. 80:323–326. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Palmisano A, Campochiaro C, Vignale D,
Tomelleri A, De Luca G, Bruno E, Monti CB, Cavalli G, Dagna L and
Esposito A: Cardiovascular involvement in Erdheim-Chester diseases
is associated with myocardial fibrosis and atrial dysfunction.
Radiol Med. 128:456–466. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bartoli L, Angeli F, Stefanizzi A,
Fabrizio M, Paolisso P, Bergamaschi L, Broccoli A, Zinzani PL,
Galiè N, Rucci P, et al: Genetics and clinical phenotype of
Erdheim-Chester disease: A case report of constrictive pericarditis
and a systematic review of the literature. Front Cardiovasc Med.
9(876294)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
De Abreu MR, Chung CB, Biswal S, Haghighi
P, Hesselink J and Resnick D: Erdheim-Chester disease: MR imaging,
anatomic, and histopathologic correlation of orbital involvement.
AJNR Am J Neuroradiol. 25:627–630. 2004.PubMed/NCBI
|
|
17
|
Hervier B, Haroche J, Arnaud L, Charlotte
F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine
O, et al: Association of both Langerhans cell histiocytosis and
Erdheim-Chester disease linked to the BRAFV600E mutation. Blood.
124:1119–1126. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang F, Cao X, Niu N, Zhang Y, Wang Y,
Feng F and Jin Z: Multisystemic imaging findings in chinese
patients with erdheim-chester disease. AJR Am J Roentgenol.
213:1179–1186. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Haroche J, Arnaud L, Cohen-Aubart F,
Hervier B, Charlotte F, Emile JF and Amoura Z: Erdheim-Chester
disease. Curr Rheumatol Rep. 16(412)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Brun AL, Touitou-Gottenberg D, Haroche J,
Toledano D, Cluzel P, Beigelman-Aubry C, Piette JC, Amoura Z and
Grenier PA: Erdheim-Chester disease: CT findings of thoracic
involvement. Eur Radiol. 20:2579–2587. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nikpanah M, Kim L, Mirmomen SM, Symons R,
Papageorgiou I, Gahl WA, O'Brien K, Estrada-Veras JI and Malayeri
AA: Abdominal involvement in Erdheim-Chester disease (ECD): MRI and
CT imaging findings and their association with BRAFV600E
mutation. Eur Radiol. 28:3751–3759. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dion E, Graef C, Haroche J, Renard-Penna
R, Cluzel P, Wechsler B, Piette JC and Grenier PA: Imaging of
thoracoabdominal involvement in Erdheim-Chester disease. AJR Am J
Roentgenol. 183:1253–1260. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gianfreda D, Palumbo AA, Rossi E,
Buttarelli L, Manari G, Martini C, De Filippo M and Vaglio A:
Cardiac involvement in Erdheim-Chester disease: An MRI study.
Blood. 128:2468–2471. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chazal T, Pegoraro F, Manari G, Bettiol A,
Maniscalco V, Gelain E, Charlotte F, Mazor RD, Renard-Penna R,
Amoura Z, et al: Clinical phenotypes and long-term outcome of
kidney involvement in Erdheim-Chester histiocytosis. Kidney Int.
103:177–186. 2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vaglio A, Palmisano A, Alberici F,
Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani
C and Buzio C: Prednisone versus tamoxifen in patients with
idiopathic retroperitoneal fibrosis: An open-label randomised
controlled trial. Lancet. 378:338–346. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang DL, Liu SB, Feng YC, Li J, Zhang T,
Wan L and Gao H: Corticosteroid combinated with cyclophosphamide in
the patients with retroperiteneal fibrosis: A clinical features and
prognostic analysis. J Clin Med. 17:18–22. 2019.
|
|
27
|
van Bommel EF, Pelkmans LG, van Damme H
and Hendriksz TR: Long-term safety and efficacy of a
tamoxifen-based treatment strategy for idiopathic retroperitoneal
fibrosis. Eur J Intern Med. 24:444–450. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Marando A, D'Ambrosio G, Catanzaro F, La
Rosa S and Sessa F: IgG4-related disease of the ureter: Report of
two cases and review of the literature. Virchows Arch. 462:673–678.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Deshpande V, Zen Y, Chan JK, Yi EE, Sato
Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, et
al: Consensus statement on the pathology of IgG4-related disease.
Mod Pathol. 25:1181–1192. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Verdalles U, Goicoechea M, García de
Vinuesa S, Mosse A and Luño J: Erdheim-Chester disease: A rare
cause of renal failure. Nephrol Dial Transplant. 22:1776–1777.
2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Elbaz Younes I, Sokol L and Zhang L:
Rosai-Dorfman disease between proliferation and neoplasia. Cancers
(Basel). 14(5271)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Balink H, Hemmelder MH, de Graaf W and
Grond J: Scintigraphic diagnosis of Erdheim-Chester disease. J Clin
Oncol. 29:e470–e472. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lin E: FDG PET/CT for biopsy guidance in
Erdheim-Chester disease. Clin Nucl Med. 32:860–861. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hervier B, Arnaud L, Charlotte F, Wechsler
B, Piette JC, Amoura Z and Haroche J: Treatment of Erdheim-Chester
disease with long-term high-dose interferon-α. Semin Arthritis
Rheum. 41:907–913. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Braiteh F, Boxrud C, Esmaeli B and
Kurzrock R: Successful treatment of Erdheim-Chester disease, a
non-Langerhans-cell histiocytosis, with interferon-alpha. Blood.
106:2992–2994. 2005.PubMed/NCBI View Article : Google Scholar
|
